Cargando…
Vaccination and Transmission Risk during the Outbreak of B.1.1.529 (Omicron)
Since its first description in November 2021, the SARS-CoV-2 variant of concern Omicron (B.1.1.529) has emerged as the dominant strain in the COVID-19 pandemic. To date, it remains unclear if boosted vaccination protects against transmission. Using data from the largest German Public Health Departme...
Autores principales: | Grüne, Barbara, Grüne, Jakob, Kossow, Annelene, Joisten, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322361/ https://www.ncbi.nlm.nih.gov/pubmed/35891167 http://dx.doi.org/10.3390/vaccines10071003 |
Ejemplares similares
-
Omicron (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistance
por: Chen, Jiahui, et al.
Publicado: (2021) -
Omicron Sub-Lineages (BA.1.1.529 + BA.*) Current Status in Ecuador
por: Carrazco-Montalvo, Andrés, et al.
Publicado: (2022) -
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
por: Andrews, Nick, et al.
Publicado: (2022) -
A study on the effect of natural products against the transmission of B.1.1.529 Omicron
por: Alkafaas, Samar Sami, et al.
Publicado: (2023) -
Importation and Transmission of SARS-CoV-2 B.1.1.529 (Omicron) Variant of Concern in Korea, November 2021
por: Lee, Ji Joo, et al.
Publicado: (2021)